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Background
T h ep r e v a l e n c eo fH I Vi n f e c t i o nh a sb e e no nt h e
increase in Nigeria in recent times. HIV-positive
patients frequently have anogenital malignancies due to
HPV. HAART was introduced in Anti-retroviral (ARV)
centers in Nigeria in the year 2002.
Purpose of the study
To determine trends in incidence of anogenital malig-
nancies among HIV-positive women undergoing treat-
ment in the clinic in the pre-HAART and HAART era.
Methods
A retrospective review of 541 case notes of HIV-positive
female patients from January 1999 to December 2004
were analyzed by utilizing an on-going observational
database at the ARV center. Rate ratios, comparing inci-
dence rates (number of malignancies per 1000 person
years) were calculated.
Results
Twenty-four (4.43%) of the patients had one form of
anogenital manifestation of HPV or the other. The inci-
dence rate for HPV rose from 2.28 in the pre-HAART
era to 6.40 in the HAART era (Rate ratio = 3.15; 95%
confidence interval (CI) =1.31 - 7.44; p= 0.0002).
Conclusions
There has been a significant rise in the incidence of
HPV since the introduction of HAART. This may be
due to the longer survival of HIV-infected patients, sur-
passing the latency period for the anogenital
malignancies. Care providers should be more vigilant for
HIV-associated malignancies as patients live longer in
this part of the world.
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